Marker Therapeutics Inc.

MRKR | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.20

+$0.02 (+1.69%)

At close: Sep 21, 2026, 4:00 PM ET

$1.20

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-12.16M	-10.73M	-14.05M	-19.78M	-41.88M	-28.71M
Depreciation & Amortization	n/a	n/a	n/a	3.68M	3.16M	1.08M
Stock-Based Compensation	537.54K	245.86K	858.27K	3.3M	n/a	5.23M
Other Working Capital	-910.73K	885.25K	861.11K	-2.36M	330.69K	2.34M
Other Non-Cash Items	n/a	n/a	-6.1M	-9.42M	5.96M	-31K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-388K	-424.87K	2.85M	-4.76M	5.47M	2.4M
Operating Cash Flow	-12.01M	-10.91M	-16.44M	-26.97M	-27.28M	-20.03M
Capital Expenditures	1	4	1	3	-3.13M	-9.25M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	18.66M	-4.95M	n/a	n/a
Investing Cash Flow	n/a	n/a	18.66M	-4.95M	-3.13M	-9.25M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	62.16K	90.48K	n/a	3.09K	550K
Financial Cash Flow	9.86M	14.99M	1.11M	202.13K	52.56M	6.74M
Net Cash Flow	-2.15M	4.08M	3.33M	-31.72M	22.14M	-22.55M
Free Cash Flow	-12.01M	-10.91M	-16.44M	-26.97M	-30.41M	-29.29M
Adj. Free Cash Flow	-12.55M	-11.16M	-17.3M	-30.28M	-30.41M	-34.52M
Maintenance CapEx	1	8	1	6	n/a	-3.98M
Growth CapEx	n/a	-4	n/a	-3	-3.13M	-5.27M
Owner Earnings	-12.01M	-10.91M	-16.44M	-26.97M	-27.28M	-24.02M